EVIPLERA 200 mg/25 mg/245 mg, comprimé pelliculé — flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 30 comprimé(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400921947359
  • CIP7 2194735
  • CIS 63578537
  • Registration number EU/1/11/737

What the source publishes

Holder
GILEAD SCIENCES IRELAND UC (IRLANDE)
Active ingredients
RILPIVIRINE, TÉNOFOVIR DISOPROXIL, EMTRICITABINE, FUMARATE DE TÉNOFOVIR DISOPROXIL, RILPIVIRINE (CHLORHYDRATE DE)
Form
comprimé pelliculé
Package
flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 30 comprimé(s)
Routes
orale
Administrative status
authorised
Supply regime
prescription initiale hospitalière annuelle ; liste I ; renouvellement non restreint
Marketing status
Déclaration de commercialisation
Authorised on
2011-11-28
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400921947359
{
  "cis": "63578537",
  "cip7": "2194735",
  "form": "comprimé pelliculé",
  "name": "EVIPLERA 200 mg/25 mg/245 mg, comprimé pelliculé — flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 30 comprimé(s)",
  "cip13": "3400921947359",
  "holder": "GILEAD SCIENCES IRELAND UC (IRLANDE)",
  "routes": [
    "orale"
  ],
  "holders": [
    "GILEAD SCIENCES IRELAND UC (IRLANDE)"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "419.61",
  "authorisedOn": "2011-11-28",
  "compositions": [
    {
      "name": "RILPIVIRINE",
      "nature": "FT",
      "strength": "25 mg",
      "linkageNumber": "2",
      "substanceCode": "27775",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    },
    {
      "name": "TÉNOFOVIR DISOPROXIL",
      "nature": "FT",
      "strength": "245 mg",
      "linkageNumber": "3",
      "substanceCode": "29337",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    },
    {
      "name": "EMTRICITABINE",
      "nature": "SA",
      "strength": "200 mg",
      "linkageNumber": "1",
      "substanceCode": "60459",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    },
    {
      "name": "FUMARATE DE TÉNOFOVIR DISOPROXIL",
      "nature": "SA",
      "strength": "300 mg",
      "linkageNumber": "3",
      "substanceCode": "89901",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    },
    {
      "name": "RILPIVIRINE (CHLORHYDRATE DE)",
      "nature": "SA",
      "strength": "27,5 mg",
      "linkageNumber": "2",
      "substanceCode": "94011",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "prescription initiale hospitalière annuelle ; liste I ; renouvellement non restreint",
  "dispensingFee": "1.02",
  "medicinePrice": "418.59",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "EVIPLERA 200 mg/25 mg/245 mg, comprimé pelliculé",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-11-20",
    "CIS_CIP_bdpm": "2026-11-20",
    "CIS_CPD_bdpm": "2026-11-20",
    "CIS_COMPO_bdpm": "2026-11-20"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 30 comprimé(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "100%"
  ],
  "marketingDeclaredOn": "2012-09-12",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "RILPIVIRINE",
    "TÉNOFOVIR DISOPROXIL",
    "EMTRICITABINE",
    "FUMARATE DE TÉNOFOVIR DISOPROXIL",
    "RILPIVIRINE (CHLORHYDRATE DE)"
  ],
  "authorisationProcedure": "Procédure centralisée",
  "prescriptionConditions": [
    "prescription initiale hospitalière annuelle",
    "liste I",
    "renouvellement non restreint"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": "EU/1/11/737",
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400921947359"